Oxaydo (Oxycodone HCl) Patent Expiration, LOE Window & CMS Spending

Oxaydo (Oxycodone HCl) by Egalet/Zyla Lif: Off-Patent Genericized (AB Competition), 11 AB generics, $10K 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorEgalet/Zyla Lif
FDA Application & PathwayN202080 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors11
2024 CMS Total Public Spend$10K
2024 Medicare Part D Spend$10K
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 32.7% 2-yr change)